Edelmann establishes Edelmann Leaflet Solutions

Published: 10-Oct-2011
Packaging Finance

New firm is a merger of two of its operations in Germany

The Edelmann Group, a German folding cartons and leaflet specialist, is bundling its activities in the leaflets business into a new company called Edelmann Leaflet Solutions.

The newly founded company will merge two of the Group’s operations in Germany – Lindauer Druckerei Eschbaumer in Lindau and Wepack in Leverkusen.

The Heidenheim-based Edelmann Group extended its leaflets business in June by installing up-to-date folding machines in its facilities and with an overall annual capacity of 1.5 billion units, it is now one Germany’s largest leaflet manufacturers.

The firm says establishing Edelmann Leaflet Solutions will allow orders to be managed outside the individual facilities in Lindau and Leverkusen. This means that capacities can be increased at short notice and the duration of projects shortened while increasing flexibility.

In total Edelmann operates 12 sites serving the healthcare and beauty sectors: in Germany (Carl Edelmann, Artur Theis, Braun Pharmadruck, Lindauer Druckerei Eschbaumer, Wesche and Wepack), France (Edelmann France), Poland (Edelmann Poland), Hungary (Zalai Nyomda), Mexico (Edelmann Mexico) and China (Edelmann Beijing) and employs around 1,500 people.

In 2010, the Group generated revenue of €188m. Worldwide it produced 4.2 billion items of folding cartons and leaflets.

See more

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Read more
Novel solution developed by Schreiner MediPharm and Edelmann

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Overcoming the hurdles of strategic market expansion Ramprasad Kaparaboyena, Regulatory Affairs Manager and QP for Pharmacovigilance at Gaelic Laboratories, discusses how to overcome the challenges of expanding your pharma market into new global regions
  2. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery capabilities and injectable dosing technology
  3. Autopack highlights best in class solutions at Packaging Innovations and Empack 2026 Leading independent integrator of packaging lines Autopack will showcase a range of its automated and semi-automated equipment at Packaging Innovations and Empack 2026, which takes place at Birmingham’s NEC from 11-12 February. The Hereford-based business will welcome visitors to come to stand V132 to find the right solution for their packaging formats and materials
  4. Global consortium launches to accelerate antibiotic discovery The $60m consortium backed by the Gates Foundation, Novo Nordisk Foundation and Wellcome aims to speed the discovery of next-generation antibiotics to tackle the growing threat of antimicrobial resistance
  5. Sharp Services invests more than €20m to expand injectables packaging capacity at its European facilities Expansion includes significant cold chain warehouse capacity to support injectable formats

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Novel solution developed by Schreiner MediPharm and Edelmann
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Packaging firms develop smarter options

While serialisation is top of most agendas, the development of Cloud-based services and smart phone solutions also offer new marketing opportunities. Susan Birks reports
Packaging

Edelmann wins Pharmapack Award for vial packaging

Third award won by folding carton concept
Packaging

Edelmann leads development of standard for tamper-evident closures

European working group will publish initial draft this year
Packaging

Edelmann increases label production capacity

Invests in folding machines at three plants
Finance

Moderna partners with Recordati to commercialise propionic acidemia mRNA therapy

The pair have entered a strategic collaboration to advance and globally commercialise its investigational propionic acidemia treatment mRNA-3927, with Moderna leading clinical development and manufacturing and Recordati responsible for worldwide commercialisation
Finance

AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration

The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery capabilities and injectable dosing technology
Subscribe now